Biomedical Investments & Innovation

Building lasting value in the life sciences through focused investment and operational expertise.

CMIL Holding is a biomedical holding company, acquiring and developing companies that advance human health. We partner with founders and researchers to scale pioneering technologies from the laboratory to the market.

Focus areas

Diagnostics

Enabling earlier, more precise diagnosis through innovative biomarker and testing technologies.

Medical Devices

Supporting the development and commercialisation of devices that improve patient outcomes.

Research Tools

Providing life science researchers with reliable, ready-to-use assay kits and testing services.

Portfolio

HaemoScan
Specialised in haemocompatibility testing, biomarker analysis for academic researchers, and ready-to-use complement activity test kits. HaemoScan serves both industry and academia with precision laboratory services.

Get in touch

For investment enquiries or partnership opportunities.

info@cmil.nl